CoMentis
South San Francisco, US · Delaware corporation
Find your way into CoMentis
Sign up to see every warm intro you have to CoMentis
- Paths you didn't know you had: your email and LinkedIn already hold routes to the CoMentis team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
MD
Michael Detke, MD, PhDExecutive
TK
Terence Kelly, PhDExecutive
DH
Daniel HuntExecutive
Board
RG
Robert G. McNeil, PhDBoard director
FM
Fred MiddletonBoard director
DH
Dennis Henner, PhDBoard director
JL
John L. HigginsBoard director
Reported raises · per SEC filings
Form D private placements$4.5M disclosed across 1 round · 2016
▶$4.5MraisedMar 2016 · 2 investors · PharmaceuticalsRule 506(b)
▶$4.5MraisedMar 2016 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Michael Detke, MD, PhDExecutive Officer
- Terence Kelly, PhDExecutive Officer, Director
- Robert G. McNeil, PhDDirector
- Daniel HuntExecutive Officer
- Fred MiddletonDirector
- Dennis Henner, PhDDirector
- John L. HigginsDirector
- Offering amount
- $12M
- Amount sold
- $4.5M
- Finders' fees
- $50K
- Placement agents
- Piper Jaffray & Co.
- First sale
- Mar 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has CoMentis raised?
- CoMentis has disclosed $4.5M raised across 1 round.
- Where is CoMentis headquartered?
- CoMentis is headquartered in South San Francisco, US.